THAR vs MTAC
Comparison between Tharimmune Inc (THAR, Company) and MedTech Acquisition Corp - Class A (MTAC, Company).
THAR vs MTAC - Performance Comparison
Key Characteristics
Financial metrics and valuation ratios
Market Cap
THAR
$183M
Winner
MTAC
$183M
Max Drawdown
THAR
99.93%
Winner
MTAC
13.92%
Sharpe Ratio
Winner
THAR
0.90
MTAC
0.44
Industry
THAR
Biotechnology
MTAC
N/A
P/E Ratio
THAR
-1.86
Winner
MTAC
-32.94
PEG Ratio
THAR
-0.01
MTAC
N/A
Debt to Equity
THAR
0.00%
MTAC
0.00%
Free Cash Flow Yield
Winner
THAR
-11.52%
MTAC
-27.91%
P/S Ratio
THAR
N/A
MTAC
12.43
P/B Ratio
THAR
N/A
MTAC
-12.13
THAR vs MTAC - Historical Returns
Returns include dividend reinvestment.
1M
THAR
-26.63%
Winner
MTAC
+7.90%
3M
THAR
-53.89%
Winner
MTAC
+9.99%
6M
THAR
+0.00%
Winner
MTAC
+11.55%
1Y
Winner
THAR
+60.14%
MTAC
+14.55%
5Y(CAGR)
THAR
-76.28%
MTAC
N/A
Max(CAGR)
THAR
-76.28%
Winner
MTAC
+3.05%
THAR vs MTAC - Annual Returns (2021 - 2026)
Returns include dividend reinvestment.
| Year | THAR | MTAC |
|---|---|---|
| 2026 | -29.88% | N/A |
| 2025 | +47.80% | N/A |
| 2024 | -73.20% | N/A |
| 2023 | -94.03% | +12.84% |
| 2022 | -88.80% | +0.80% |
| 2021 | N/A | -6.08% |
THAR vs MTAC Drawdown Comparison
The maximum drawdown for THAR was -99.93%, occurring on Apr 9, 2025. This drawdown has not yet recovered.
The maximum drawdown for MTAC was -13.92%, occurring on Mar 7, 2022. Recovery took 622 trading sessions.
The current THAR drawdown is -99.85%.
| Rank | THAR | MTAC |
|---|---|---|
| #1 | -99.93% Feb 2, 2022 - Apr 9, 2025 | -13.92% Feb 19, 2021 - Aug 10, 2023 |
| #2 | -26.15% Jan 12, 2022 - Jan 24, 2022 | -1.90% Feb 8, 2021 - Feb 16, 2021 |
| #3 | -2.13% Jan 24, 2022 - Jan 27, 2022 | N/A |
| #4 | -1.87% Jan 31, 2022 - Feb 2, 2022 | N/A |
Correlation
Correlation between THAR and MTAC is -0.37 which considered as a weak negative correlation - the stocks show a slight tendency to move in opposite directions.
-0.37
-101
Select Stocks to Compare
Popular: THAR vs SPYMTAC vs SPY
More Comparisons
Compare with similar stocks